Oxbridge Re (NASDAQ:OXBR) Announces Earnings Results

Oxbridge Re (NASDAQ:OXBR) issued its earnings results on Thursday. The insurance provider reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.01), FiscalAI reports. The firm had revenue of $0.94 million during the quarter, compared to analysts’ expectations of $1.10 million. Oxbridge Re had a negative return on equity of 33.33% and a negative net margin of 76.47%.

Here are the key takeaways from Oxbridge Re’s conference call:

• Oxbridge returned to profitability, reporting second-quarter net income of $176,000, or $0.02 per share, versus a $1.87 million loss in the prior-year quarter. The improvement was driven by no underwriting losses, higher SurancePlus management-fee income, and lower professional fees and compensation.
• SurancePlus expanded beyond Oxbridge-originated reinsurance by closing five tokenized offerings, including three third-party opportunities from HCI Group and Fortex Re, raising $7.1 million in aggregate gross proceeds. Prior-year offerings exceeded their targeted annual returns, although the newer return targets assume no underwriting losses.
• Net premiums earned declined to $368,000 in the quarter and $924,000 for the first six months, versus $582,000 and $1.1 million, respectively, a result of lower weighted-average rates and less capital deployed into reinsurance contracts.
• Oxbridge launched AI GridWorks to develop, own, and operate 10- to 100-megawatt AI data centers, initially targeting the southeastern U.S. The company sees multiple monetization and financing options—including selling entitled, powered land, leasing data-center capacity, operating facilities, and eventually tokenizing interests—but the initiative remains in the development stage.
• Restricted cash and cash equivalents increased to $19.82 million as of June 30, 2026, from $6.98 million at year-end 2025, reflecting new tokenized-security investments, released collateral, and premium deposits.

Oxbridge Re Stock Performance

Shares of OXBR stock traded up $0.11 during trading hours on Thursday, reaching $1.30. The company had a trading volume of 1,044,618 shares, compared to its average volume of 22,731. The business has a fifty day moving average price of $1.26 and a 200-day moving average price of $1.07. Oxbridge Re has a one year low of $0.66 and a one year high of $2.86. The firm has a market cap of $10.53 million, a PE ratio of -5.20 and a beta of 1.94. The company has a debt-to-equity ratio of 0.16, a quick ratio of 8.15 and a current ratio of 8.15.

Institutional Investors Weigh In On Oxbridge Re

An institutional investor recently bought a new position in Oxbridge Re stock. Virtu Financial LLC acquired a new stake in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 17,789 shares of the insurance provider’s stock, valued at approximately $32,000. Virtu Financial LLC owned about 0.23% of Oxbridge Re as of its most recent filing with the Securities and Exchange Commission (SEC). 5.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently weighed in on OXBR. Maxim Group reduced their price target on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating for the company in a research report on Tuesday, June 16th. Weiss Ratings upgraded Oxbridge Re from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, July 28th. Finally, Zacks Research raised Oxbridge Re to a “hold” rating in a report on Wednesday, June 17th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $3.00.

About Oxbridge Re

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.